Results 271 to 280 of about 8,810,905 (348)
A manifesto for a globally diverse, equitable, and inclusive open science. [PDF]
Ghai S +10 more
europepmc +1 more source
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande +11 more
wiley +1 more source
Open science interventions to improve reproducibility and replicability of research: a scoping review. [PDF]
Dudda L +10 more
europepmc +1 more source
Aggressive prostate cancer is associated with pericyte dysfunction
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero +11 more
wiley +1 more source
openaire +3 more sources
Disruptive Technologies and Open Science: How Open Should Open Science Be? A 'Third Bioethics' Ethical Framework. [PDF]
Spitale G, Germani F, Biller-Andorno N.
europepmc +1 more source
Collaborative Web between open and closed science (Italian original version)
Alessandro Delfanti
openalex +1 more source
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard +12 more
wiley +1 more source
Onwards! Open science and the (PLOS) genetics community. [PDF]
Dudley AM, Goriely A, Squarr J.
europepmc +1 more source

